CN1413680A - Chinese medicine for treating hyperosteogeny - Google Patents

Chinese medicine for treating hyperosteogeny Download PDF

Info

Publication number
CN1413680A
CN1413680A CN 02133952 CN02133952A CN1413680A CN 1413680 A CN1413680 A CN 1413680A CN 02133952 CN02133952 CN 02133952 CN 02133952 A CN02133952 A CN 02133952A CN 1413680 A CN1413680 A CN 1413680A
Authority
CN
China
Prior art keywords
grams
radix
rhizoma
chinese medicine
herba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 02133952
Other languages
Chinese (zh)
Other versions
CN1176705C (en
Inventor
罗孝华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB02133952XA priority Critical patent/CN1176705C/en
Publication of CN1413680A publication Critical patent/CN1413680A/en
Application granted granted Critical
Publication of CN1176705C publication Critical patent/CN1176705C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

A Chinese medicine in the form of medical wine, powder, pill, or capsule for treating hyperosteogeny and rheumatic arthritis is prepared from 32 Chinese-medicinal materials including Chinese angelica root, Chuan-xiong rhizome, astragalus root, coix seed, etc. Its advantages are high effective rate up to 99%, high cure rate (more than 98%), and low cost.

Description

A kind of Chinese medicine for the treatment of hyperosteogeny
Technical field
The present invention relates to Chinese medicine, particularly a kind of Chinese medicine for the treatment of hyperosteogeny.
Background technology
The treatment hyperosteogeny adopts sealing more in the prior art, and operative treatment is limited to, easily recurrence, and with plaster external application, Chinese herbal medicine for oral administration, effect is undesirable.
Summary of the invention
The objective of the invention is to: provide a kind of Chinese medicine for the treatment of hyperosteogeny, but this medicine not only oral administration but also external application cure mainly hyperosteogeny, and rheumatism, arthritis are also had specially good effect, can reach the high purpose of good effect and cure rate.
Formation of the present invention: it is made up of the material medicine of following consumption: Radix Angelicae Sinensis 30～40 grams, Rhizoma Chuanxiong 50～60 grams, the Radix Astragali 60～100 grams, Herba Epimedii 30～50 grams, the Cortex Eucommiae 30～80 grams, the Radix Angelicae Dahuricae 40～60 grams, Bi  40～60 grams, Rhizoma Atractylodis 40～100 grams, Radix Angelicae Pubescentis 30～80 grams, Radix Achyranthis Bidentatae 40～80 grams, Fructus Chaenomelis 40～80 grams, Radix Stephaniae Tetrandrae 40～60 grams, Herba Taxilli 40～80 grams, Rhizoma Cibotii 40～80 grams, Cortex Acanthopancis 40～80 grams, Semen Coicis 30～80 grams, Rhizoma Drynariae 40～80 grams, Rhizoma Homalomenae 40～70 grams, Radix Gentianae Macrophyllae 60～70 grams, the Radix Aucklandiae 40～60 grams, the Radix Linderae 40～80 grams, rhizoma sparganic 20～40 grams, Rhizoma Curcumae 20～40 grams, Olibanum 20～40 grams, Myrrha 20～40 grams, Caulis Sargentodoxae 40～70 grams, Radix Dipsaci 40～70 grams, Ramulus Cinnamomi 40～80 grams, Herba Asari 10～25 grams, Fructus Schisandrae Chinensis 10～15 grams, Radix Clematidis 40～70 grams, Radix Notoginseng 10～30 grams, make medicated wine with conventional method, powder, ball or capsule are for oral administration, also can make the cream external.
Compared with the prior art, it is for oral administration that the present invention can be made into medicated wine, powder, ball or capsule, also can make the cream external, cures mainly hyperosteogeny, and rheumatism, arthritis are also had specially good effect, and cost is low, good effect, and effective percentage reaches 99%, and cure rate reaches 98%.
The specific embodiment
Get Radix Angelicae Sinensis 30 grams, Rhizoma Chuanxiong 50 grams, the Radix Astragali 60 grams, Herba Epimedii 30 grams, the Cortex Eucommiae 30 grams, the Radix Angelicae Dahuricae 40 grams, Bi  40 grams, Rhizoma Atractylodis 40 grams, Radix Angelicae Pubescentis 30 grams, Radix Achyranthis Bidentatae 40 grams, Fructus Chaenomelis 40 grams, Radix Stephaniae Tetrandrae 40 grams, Herba Taxilli 40 grams, Rhizoma Cibotii 40 grams, Cortex Acanthopancis 40 grams, Semen Coicis 30 grams, Rhizoma Drynariae 40 grams, Rhizoma Homalomenae 40 grams, Radix Gentianae Macrophyllae 60 grams, the Radix Aucklandiae 40 grams, the Radix Linderae 40 grams, rhizoma sparganic 20 grams, Rhizoma Curcumae 20 grams, Olibanum 20 grams, Myrrha 20 grams, Caulis Sargentodoxae 40 grams, Radix Dipsaci 40 grams, Ramulus Cinnamomi 40 grams, Herba Asari 10 grams, Fructus Schisandrae Chinensis 10 grams, Radix Clematidis 40 grams, Radix Notoginseng 10 grams, make medicated wine with conventional method, powder, ball or capsule are for oral administration, also can make the cream external.

Claims (1)

1. Chinese medicine for the treatment of hyperosteogeny, it is characterized in that: it is made up of the material medicine of following consumption: Radix Angelicae Sinensis 30～40 grams, Rhizoma Chuanxiong 50～60 grams, the Radix Astragali 60～100 grams, Herba Epimedii 30～50 grams, the Cortex Eucommiae 30～80 grams, the Radix Angelicae Dahuricae 40～60 grams, Bi  40～60 grams, Rhizoma Atractylodis 40～100 grams, Radix Angelicae Pubescentis 30～80 grams, Radix Achyranthis Bidentatae 40～80 grams, Fructus Chaenomelis 40～80 grams, Radix Stephaniae Tetrandrae 40～60 grams, Herba Taxilli 40～80 grams, Rhizoma Cibotii 40～80 grams, Cortex Acanthopancis 4080 grams, Semen Coicis 30～80 grams, Rhizoma Drynariae 40～80 grams, Rhizoma Homalomenae 40～70 grams, Radix Gentianae Macrophyllae 60～70 grams, the Radix Aucklandiae 40～60 grams, the Radix Linderae 40～80 grams, rhizoma sparganic 20～40 grams, Rhizoma Curcumae 20～40 grams, Olibanum 20～40 grams, Myrrha 20～40 grams, Caulis Sargentodoxae 40～70 grams, Radix Dipsaci 40～70 grams, Ramulus Cinnamomi 40～80 grams, Herba Asari 10～25 grams, Fructus Schisandrae Chinensis 10～15 grams, Radix Clematidis 40～70 grams, Radix Notoginseng 10～30 grams, make medicated wine with conventional method, powder, ball or capsule are for oral administration, also can make the cream external.
CNB02133952XA 2002-10-21 2002-10-21 Chinese medicine for treating hyperosteogeny Expired - Fee Related CN1176705C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB02133952XA CN1176705C (en) 2002-10-21 2002-10-21 Chinese medicine for treating hyperosteogeny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB02133952XA CN1176705C (en) 2002-10-21 2002-10-21 Chinese medicine for treating hyperosteogeny

Publications (2)

Publication Number Publication Date
CN1413680A true CN1413680A (en) 2003-04-30
CN1176705C CN1176705C (en) 2004-11-24

Family

ID=4747482

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB02133952XA Expired - Fee Related CN1176705C (en) 2002-10-21 2002-10-21 Chinese medicine for treating hyperosteogeny

Country Status (1)

Country Link
CN (1) CN1176705C (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1306948C (en) * 2004-06-18 2007-03-28 刘国仁 Capsule for treating osteoporosis and its preparing method
CN100420478C (en) * 2006-04-21 2008-09-24 代北仓 A medicine for treating hyperosteogeny and preparation method thereof
CN101032569B (en) * 2007-04-03 2010-09-08 蒋坤元 Medicine drink good for spine
CN101703664B (en) * 2009-12-01 2011-04-13 王幸福 Chinese medicinal composition for treating hyperosteogeny
CN103705801A (en) * 2013-12-23 2014-04-09 王友强 Chinese medicament decoction for treating hyperostosis
CN103816387A (en) * 2014-03-09 2014-05-28 邱光学 External traditional Chinese medicine plaster for treating osteoproliferation and preparation method thereof
CN104771654A (en) * 2015-04-24 2015-07-15 杨帮德 Traditional Chinese medicine for treating lumbar vertebra hyperostosis and cervical vertebra hyperostosis and preparation method thereof

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1306948C (en) * 2004-06-18 2007-03-28 刘国仁 Capsule for treating osteoporosis and its preparing method
CN100420478C (en) * 2006-04-21 2008-09-24 代北仓 A medicine for treating hyperosteogeny and preparation method thereof
CN101032569B (en) * 2007-04-03 2010-09-08 蒋坤元 Medicine drink good for spine
CN101703664B (en) * 2009-12-01 2011-04-13 王幸福 Chinese medicinal composition for treating hyperosteogeny
CN103705801A (en) * 2013-12-23 2014-04-09 王友强 Chinese medicament decoction for treating hyperostosis
CN103816387A (en) * 2014-03-09 2014-05-28 邱光学 External traditional Chinese medicine plaster for treating osteoproliferation and preparation method thereof
CN103816387B (en) * 2014-03-09 2016-03-09 邱光学 A kind of external Chinese medicinal plaster and preparation method for the treatment of bone matrix hyperplasia
CN104771654A (en) * 2015-04-24 2015-07-15 杨帮德 Traditional Chinese medicine for treating lumbar vertebra hyperostosis and cervical vertebra hyperostosis and preparation method thereof
CN104771654B (en) * 2015-04-24 2018-04-20 杨帮德 Treat Chinese medicine of lumbar vertebrae, cervical vertebrae hyperosteogeny and preparation method thereof

Also Published As

Publication number Publication date
CN1176705C (en) 2004-11-24

Similar Documents

Publication Publication Date Title
CN103356961B (en) Traditional Chinese medicinal composition for treating amenorrhoea
CN100496586C (en) Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion
CN101134085A (en) Traditional Chinese medicine for treating apoplectic hemiplegia
CN101129617A (en) Traditional Chinese medicine for treating liver cirrhosis
CN101062212A (en) Chinese medicinal herb composition for treating gastritis
CN103356968B (en) Traditional Chinese medicine composition for treating endometriosis
CN1562263A (en) External use ointment of Chinese traditional medicine for curing gynecopathy
CN1413680A (en) Chinese medicine for treating hyperosteogeny
CN103446554A (en) Traditional Chinese medicine composition for treating scapulohumeral periarthritis
CN1140291C (en) Stone-eliminating Jinyin medicine powder
CN101757206A (en) Chinese medicine preparation for treating chronic colitis
CN101167969A (en) Traditional Chinese medicine for treating meniere's syndrome
CN1418693A (en) Oral liquid medicine for treating stomach-pain, and its prepn. method
CN101152540A (en) Traditional Chinese medicine for treating chronic hepatitis
CN103623385A (en) Traditional Chinese medicine for treating dental ulcer
CN102114235A (en) External Chinese herbal preparation for treating woman lobular hyperplasia of mammary glands and preparation method thereof
CN101130003A (en) Traditional Chinese medicine for treating acute cholecystitis
CN101152394A (en) Traditional Chinese medicine for treating chronic active hepatitis
CN1457856A (en) Compound toxin-eliminating bolus
CN101897923A (en) Chinese medicinal powder for treating nighttime lumbago
CN102949684B (en) Medicine formula for treating rheumatoid arthritis
CN1457855A (en) Yin-toxin source eliminating pill
CN101129709A (en) Traditional Chinese medicine for treating old fracture and lumbago of old people
CN101991696A (en) Chinese material medical preparation for treating urticaria
CN1223119A (en) Traditional Chinese medicinal preparation for curing gynecopathy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee